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Abstract 32 
Insulin has long been recognized as a key regulator of energy homeostasis via its actions at the level of 33 
the brain, but in addition, plays a role in regulating neural control of reproduction.  In this review, we 34 
consider and compare evidence from animal models demonstrating a role for insulin for physiological 35 
control of reproduction by effects on GnRH/LH secretion.  We also review the role that insulin plays 36 
in prenatal programming of adult reproduction, and consider specific candidate neurons in the adult 37 
hypothalamus by which insulin may act to regulate reproductive function.  Finally, we review clinical 38 
evidence of the role that insulin may play in adult human fertility and reproductive disorders.  Overall, 39 
while insulin appears to have a significant impact on reproductive neuroendocrine function, there are 40 
many unanswered questions regarding its precise sites and mechanisms of action, and their impact on 41 
developing and adult reproductive neuroendocrine function. 42 
 43 
Highlights 44 
• Insulin plays a key role in the regulation of reproduction in addition to metabolism 45 
• Insulin regulates both pulsatile and surge secretion of GnRH/LH 46 
• Insulin may be a signal in prenatal programming of adult reproductive function 47 
• Insulin targets in the brain include kisspeptin, AgRP and POMC neurons 48 
• Insulin resistance in human disease is associated with reproductive dysfunction 49 
 50 
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1. Reproduction and energy balance: the functional connection in health and disease 54 
 55 
Reproduction is a crucial function of the organism and is controlled by complex interactions between 56 
the hypothalamus, pituitary and gonads, the so-called hypothalamic-pituitary-gonadal (HPG) axis [1]. 57 
However, reproduction and the survival of offspring is also an energetically demanding process, and 58 
the relationship between reproductive success and energy balance is well established. Energy is stored 59 
primarily as fat and glycogen, and together with glucose, allows organisms to grow and reproduce [2]. 60 
However, an animal’s energy stores depend not only on the availability of energy sources (food), but 61 
also on energy expenditure. Pregnancy, parturition, lactation and maternal behavior are all 62 
energetically demanding states and in order to be successful in reproducing, the organism must be able 63 
to monitor energy status. Thus, negative energy balance either due to hypophagia (e.g. fasting, 64 
anorexia nervosa, and cachexia) or excessive energy expenditure (e.g. excessive exercize-induced 65 
amenorrhea and lactation) is linked to a suppression of reproductive function and ovarian cyclicity in a 66 
variety of species including humans [2, 3].  67 
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 68 
Since its discovery by Banting and Best in 1921 [4], insulin has been recognized as a key circulating 69 
signal mediating energy homeostasis. While major role of insulin is to maintain peripheral glucose 70 
homeostasis, via stimulation of glucose uptake, oxidation and storage [5], there is also strong evidence 71 
that insulin plays a role in regulating reproduction and may serve as a major signal linking metabolism 72 
and reproductive status.  In this review we will focus on the role of insulin as an important factor in 73 
the control of reproduction, through actions occurring not only in the periphery but also in the central 74 
nervous system (CNS). We will review evidence primarily from animal studies demonstrating a role 75 
of insulin in the regulation of reproduction during adulthood, as well as during fetal development. In 76 
addition, we will examine evidence for potential CNS targets of insulin action specifically related to 77 
reproduction.  Finally we will discuss the clinical relevance of the relationship between insulin and 78 
reproduction, with a specific focus on potential neural sites of action.   79 
 80 
2. Insulin as a signal in the metabolic control of adult reproduction 81 
 82 
2.1. Insulin: its major role in controlling glucose homeostasis  83 
 84 
In a simple sense, physiological maintenance of the regulation of blood glucose levels is the result of 85 
the coordinated function of three organs: the pancreas, which secretes insulin in response to increases 86 
in blood glucose; the liver, which decreases glucose production in response to raising levels of insulin; 87 
and skeletal muscle (and other tissues) that respond to insulin by increasing glucose uptake. In 88 
addition to this role, insulin also plays an important function in fat and protein metabolism, as it 89 
promotes the transport of amino acids from the bloodstream into muscle and other tissues/cells. Acting 90 
within cells, insulin increases the rate of incorporation of amino acids into protein and reduces protein 91 
breakdown. Moreover, insulin stimulates lipid (fat) synthesis from carbohydrate (in the process called 92 
lipogenesis) and decreases fatty acid release from tissue (in the process called lipolysis), leading to an 93 
increase in total body lipid stores [6]. Finally, insulin also possesses important vascular actions, such 94 
as vasodilatation, which leads to increase in the blood flow, and subsequent augmentation of glucose 95 
disposal in classic insulin target tissues [7, 8].  96 
 97 
2.2. Evidence for a role for insulin in the control of the HPG axis 98 
 99 
Metabolism and reproduction are closely interlinked and a large body of research has focused on 100 
elucidating the mechanism by which signals from the periphery are conveyed to the HPG axis under 101 
various metabolic states. The master molecule for the control of the HPG system in mammals is the 102 
decapeptide, gonadotropin-releasing hormone (GnRH).  GnRH is synthesized by a relatively small 103 
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number of neurons, whose cell bodies are dispersed over an area that extends from the rostral ventral 104 
forebrain to the caudal hypothalamus and varies between species [9-11]. GnRH neurons send a major 105 
axonal projection to the median eminence [12-14], where GnRH is secreted into the pituitary portal 106 
system, and subsequently causes the release of luteinizing hormone (LH) from gonadotrophs of the 107 
anterior pituitary [16]. There are two major modes of GnRH secretion: the tonic or episodic secretion 108 
of GnRH that is seen in both males and females, and the preovulatory surge secretion of GnRH which 109 
is responsible for triggering ovulation and occurs only in females Both pulsatile and surge modes of 110 
GnRH secretion are sensitive to metabolic signals [18-22]  and pathological situations which lead to 111 
acute and/or chronic hypo- or hyperinsulinemia are frequently coupled with disturbed GnRH/LH pulse 112 
and surge release patterns.  113 
 114 
The importance of insulin as a regulator of GnRH/LH pulses remains to be fully elucidated as results 115 
vary considerably between studies and the effects of insulin per se are difficult to tease apart from the 116 
role of accompanying peripheral signals and metabolites. For example, in diabetic male rats, there was 117 
a 50% reduction in LH pulse frequency and amplitude compared to non-diabetic controls [18]. Those 118 
deficits were completely reversed by twice daily insulin treatment [18]. Similarly, in Streptozotocin-119 
induced (STZ-induced) diabetic male lambs, 24h withdraw from insulin supplementation decreased 120 
LH pulse frequency and acute re-supplementation reversed the inhibition [19]. However, in this study, 121 
a longer-term insulin withdrawal (96h) exaggerated the effects on LH (with a further reduction in LH 122 
pulses) during which insulin and glucose plasma concentrations remained constant. Therefore, other 123 
suppressors such as non-esterified fatty acids and ketone bodies cannot be ruled out [19]. By contrast, 124 
studies of other hypoinsulinemic models such as fasting yield different results. In adult (non-diabetic) 125 
male rhesus monkeys that underwent 24 h of fasting a profound suppression of LH was recorded, and 126 
rapid re-feeding reversed those deficits. To test the possible role of insulin, on the day of re-feeding, 127 
post-meal insulin secretion was partially suppressed by diazoxide (40-99%). However, this treatment 128 
did not block the LH increase observed after feeding [23] indicating that insulin alone was could not 129 
account for the observed inhibition. Similarly a central role of insulin in regulating GnRH/LH pulses 130 
remains controversial. Hileman et al. [24] reported that central injection of insulin (lateral ventricle) 131 
did not increase LH secretion in the growth-restricted, hypogonadotropic lamb. By contrast, Miller et 132 
al. [25] found that the infusion of insulin into the third ventricle stimulated pulsatile LH secretion in 133 
adult male sheep. In a male diabetic sheep model, insulin infusion in the lateral ventricle reversed the 134 
decrease in LH pulse frequency but not to the same extent as peripheral insulin, providing further 135 
evidence that insulin alone cannot account for the diabetes-induced deficit in LH pulses. The reason 136 
for the discrepancy between these studies is not known, however, differences may be due to the type 137 
of model used (diabetic vs. fasting models), the doses, infusion site, and rate of insulin administered 138 
(pharmacological vs. supraphysiological; lateral vs. third ventricle; acute vs. chronic), the species 139 
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(polygastric vs. monogastric animals) and the level of hypoinsulinemia [complete (diabetes) vs. partial 140 
(fasting)].  141 
 142 
Despite variable results, the above studies taken together suggest that the peripheral and central actions 143 
of insulin are permissive rather than necessary for normal GnRH/LH pulsatile secretion.  144 
In addition to GnRH/LH pulses, the GnRH/LH surge is also sensitive to metabolic cues. Models of 145 
negative energy balance induced by fasting, caloric restriction and lactation are accompanied by a 146 
decrease in circulating insulin and disruption of estrous cyclicity in a number of species such as rats 147 
[26, 27], ewes [28], heifers [29] and monkeys [30]. Specifically, in adult female rats, short-term food 148 
deprivation blocks the LH surge [31, 32]. Short-term fasting during the luteal phase of the estrous 149 
cycle in sheep, increased serum concentrations of progesterone and delayed or diminished the pre-150 
ovulatory LH surge [33, 34]. Data on the role of insulin in these disruptions are lacking, however, 151 
insulin replacement during lactational anestrous- a model of severe undernutrition did not restore 152 
estrous cyclicity [35]. Therefore, it is likely that other metabolic signals, such as hypoglycemia, leptin, 153 
or even the activation of the stress axis may be responsible for these disruptions [35, 36]. Experimental 154 
diabetes induced in female rats with STZ [37], a state of extreme hypoinsulinemia, results in impaired 155 
ovulation rates over an extended period of observation, disruption of the positive feedback effects of 156 
estradiol, and absent or delayed LH surges [20, 38, 39]. However, in this model, reproductive 157 
abnormalities are at least partially reversed after peripheral insulin administration [40]. These results 158 
are similar to those described above, in that effects on pulsatile and surge secretion are not reversed by 159 
insulin during negative energy balance but are at least partially reversed in diabetic models 160 
(hypoinsulinemia vs. extreme hypoinsulinemia).  161 
 162 
Another commonly used experimental model for metabolic stress is insulin-induced hypoglycemia 163 
(IIH).  This model mimics the detrimental effects of an acute decrease in energy availability, but also 164 
the effects of iatrogenic insulin overdose in diabetic patients. Even though the individual roles of 165 
supraphysiological amounts of insulin and the acute hypoglycemia are difficult to tease apart, there are 166 
several pieces of evidence that suggest that insulin does indeed contribute to the GnRH surge 167 
disruption during IIH. Studies carried out in ewes have determined that IIH  during the activation, 168 
transmission or secretory phases of the GnRH surge mechanism [41, 42] initiates a sudden activation 169 
of the hypothalamic-pituitary-adrenal (HPA) axis [43, 44] resulting in a delayed and reduced 170 
amplitude LH surge in the majority of treated ewes [42, 43, 45].  By contrast, there are reports of no 171 
effect of IIH on the LH surge of proestrous rats [46] and monkeys [47]; however, the doses of insulin 172 
used in these studies were significantly less than those used in the sheep experiments, suggesting that a 173 
specific threshold of hyperinsulinemia/hypoglycemia may need to be reached for deleterious effects to 174 
occur. Glucose replacement in the IIH sheep model reverses the effects of IIH on the timing of the 175 
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surge [48] but not on its amplitude [42]. Therefore, even though the timing of the LH surge appears to 176 
be sensitive to glucose availability, surge amplitude does not, and it may be that hyperinsulinemia in 177 
this experimental model is responsible for this effect.  178 
 179 
Similar conclusions can be drawn from experiments in sheep that have been prenatally exposed to 180 
excess testosterone and exhibit metabolic and reproductive deficits similar to those seen in women 181 
with polycystic ovarian syndrome (PCOS) [49, 50]. Prenatal testosterone treated female ewes display 182 
hyperinsulinemia and insulin resistance [50], as well as defects in steroid feedback control of LH 183 
secretion, including delayed and reduced amplitude LH surges [51]. Interestingly, in this model, 184 
restoration of cumulative plasma insulin levels with an insulin sensitizer, rosiglitazone, was able to 185 
restore the amplitude but not the timing of the LH surge [52]. Taken together, data from these two 186 
sheep models (IIH and prenatal testosterone exposure) imply that hyperinsulinemia does not abolish 187 
the LH surge but does reduce its amplitude. Whether this is a result of decreased GnRH release and/or 188 
reduced pituitary responsiveness to GnRH remains to be determined, however, there is evidence that 189 
both these sites are involved. For example, in women with PCOS pituitary response to GnRH is 190 
suppressed under a euglycemic, hyperinsulinemic clamp [53] and this may account for the reduced 191 
surge amplitude observed in the prenatal testosterone treated ewe model. Similarly, substantial 192 
evidence suggests that insulin acts directly within the hypothalamus, and specifically via insulin 193 
receptor (IR) containing cells to influence GnRH excitability (see section 4.2).  The site(s) of action 194 
(neural vs pituitary) of insulin in regulating both pulsatile and surge secretion of GnRH/LH may be 195 
best addressed by future studies using the sheep model, where a specific advantage is the ability to 196 
repeatedly measure GnRH in portal blood in awake animals [54]. 197 
 198 
 199 
3. Insulin: its potential role in prenatal programming of reproduction  200 
 201 
There is a growing body of both epidemiological and experimental evidence indicating that 202 
environmental factors can act early in the development to shape relationships between the regulation 203 
of energy status and reproduction later in life. The concept that early environmental factors can 204 
permanently organize or imprint physiological and behavioral systems is called fetal or early 205 
programming [55-58]. This hypothesis originated from studies indicating that low birth weight is 206 
associated with an increased biological risk for coronary heart disease in adult life [55]. Later studies 207 
performed by Philips and collaborators [59-61] demonstrated a strong correlation between low birth 208 
weight, high cortisol levels and development of hypertension and Type 2 diabetes. There is now a 209 
good body of evidence, both from epidemiological data and experimental studies in animals, linking 210 
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the intrauterine environment with the development of hypertension, diabetes, elevated blood 211 
cholesterol and PCOS in adulthood (for review see [55, 62, 63]). 212 
 213 
Several not mutually exclusive hypotheses have been developed to explain a link between a low body 214 
weight at birth and later adult risk of metabolic syndrome. “The Fetal Insulin Hypothesis” states that 215 
pancreatic beta cell dysfunction can lead to defects in glucose stimulated insulin secretion, which in 216 
turn lead to reduced insulin mediated fetal growth and a low birth weight [64]. Those alterations at 217 
early stages would later in adulthood result in defects in beta cells and decreased insulin sensitivity, 218 
and thereby affect whole body glucose metabolism. Interestingly, however, Ng et al. [65], using a rat 219 
model of chronic high fat diet, reported that not only maternal but also paternal metabolic status could 220 
affect offspring health. Specifically, they found that the female offspring of males fed a high fat diet in 221 
adulthood showed impaired glucose tolerance and insulin secretion. Moreover, the gene-expression 222 
profile of the insulin-secreting pancreatic islet cells obtained from the daughters was abnormal, with 223 
changes in multiple gene networks and cellular pathways.  The authors speculated that exposure to a 224 
high fat diet may have affected spermatogenesis in those fathers, re-programming the gametes 225 
possibly via epigenetic mechanisms.  226 
 227 
Another explanation of the relationship between body weight at birth and adult metabolic syndrome 228 
comes from the “Thrifty Phenotype Hypothesis”, according to which a fetus that endures poor 229 
nutrition during gestation, would spare the growth of vital organs, e.g. the brain, at the expense of 230 
tissues such as the muscle and the endocrine pancreas [66]. Thus, the fetus would adapt its metabolism 231 
to conditions of limited nutrition with permanent changes in insulin and glucose metabolism, 232 
increasing the risk of adult Type 2 diabetes and the metabolic syndrome [66]. In the light of evidence 233 
discussed above it would be of particular interest to identify the regions of the brain affected by early 234 
nutritional insults. We speculate that hypothalamus, where information about nutritional status is 235 
“read”, and which plays a key role in governing reproduction, could be one such region. In support of 236 
this, recent studies using an intrauterine growth restriction rat model (maternal low protein restriction) 237 
found impaired insulin signaling in the hypothalamus in 20 days old pups [67]. Specifically, tyrosine 238 
phosphorylation levels of IRS2 and PIK3 p85α were impaired, changes which could potentially block 239 
insulin signal transduction. However, it is not known if these hypothalamic changes in insulin 240 
signaling pathway components persist into puberty and adulthood, or whether they play a causal role 241 
in affecting later metabolic or reproductive function. 242 
 243 
Of particular interest for the current review are also findings suggesting that the adverse environmental 244 
factors are related to intrauterine growth retardation (IUGR) and low birth weight may predispose 245 
individuals to the later onset of development of metabolic syndrome, and that those individuals may 246 
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also have reproductive system abnormalities. Based on those findings, a hypothesis termed the 247 
developmental origins of health and disease (DOHaD) has been developed [68], which states that an 248 
adverse perinatal environment programs or imprints the development of several tissues. In agreement 249 
with this concept, perinatal perturbations of the fetus/neonate nutrient supply might be a crucial 250 
determinant of individual programming of body weight set-point. The best-known example of the 251 
influence of negative metabolic status is the Dutch Famine Study, in which fetuses exposed to famine 252 
during early pregnancy had a higher energy intake and adiposity in adulthood [69, 70].  Importantly, 253 
prenatal growth restraint, followed by postnatal catch-up growth has been associated with relative 254 
hyperinsulinism, increased visceral fat, FSH hypersecretion, development of exaggerated adrenarche 255 
with reduced uterine and ovarian size, reduced ovulation rate in adolescent girls and early post-256 
menarche (for review see [71, 72]) as well as an advanced tempo of pubertal development and 257 
menarche [72].  Moreover, during the post-menarcheal period, girls born with low body weight have 258 
increased risk of developing PCOS, a disorder of androgen excess (in particular elevated free 259 
testosterone levels) as well as ovarian and metabolic dysfunctions [73-75]. Furthermore, women with 260 
PCOS demonstrated higher risk of developing of gestational diabetes mellitus (GDM) [76] and 261 
approximately 40% of PCOS women are insulin resistant [77]. Although PCOS manifests clinically 262 
during adolescence, the disease may originate in intrauterine life [78]. Importantly, experiments in 263 
sheep that have been prenatally exposed to excess testosterone lead to adult metabolic and 264 
reproductive deficits similar to those seen in women with PCOS [49, 50].  265 
 266 
Thus, both epidemiological studies and animal models indicate that nutritional status during gestation 267 
has long-term effects on central and peripheral systems that regulate energy balance and reproduction 268 
in the developing offspring. Moreover, perinatal nutrition impacts susceptibility to developing 269 
metabolic disorders and plays a role in programming body weight set points (for an review see [79]). 270 
Those observations led to the hypothesis of metabolic imprinting, according to which a stimulus or 271 
insult occurring during a critical period of development has a long-term effect on the physiologic and 272 
metabolic responses of the offspring (for review see [80]). However, the role of altered neural 273 
organization in effects of prenatal programming by nutrients has not been studied in the same degree 274 
of detail as the role of peripheral organ function. Insulin, which is increased in offspring of fat-fed 275 
dams [81], and insulin-like growth factors, are thought to be pivotal to neuronal differentiation, as well 276 
as synapse formation and consolidation, in the hypothalamus [82] which plays a crucial role in 277 
regulation of appetite and food intake [83, 84]. As insulin and leptin are two important hormonal 278 
signals, which are secreted into the bloodstream in proportion to the amount of adipose tissue, they are 279 
often studied in the animal models discussed above [85]. Those hormones are blood-borne and cross 280 
the brain-blood barrier to act upon the brain, including the arcuate nucleus of the hypothalamus 281 
(ARC). Within the ARC, neuropeptide Y (NPY), agouti-related peptide (AgRP) and 282 
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proopiomelanocortin (POMC) are synthesized and released [86-89]. NPY acts to stimulate food intake 283 
and reduce energy expenditure via interactions with receptors located in the paraventricular nucleus of 284 
the hypothalamus (PVN) and the lateral hypothalamus area (LHA).  POMC neurons release alpha-285 
melanocyte-stimulating hormone (α-MSH), which acts in the PVN and LHA on melanocortin 286 
receptors to decrease intake and increase energy expenditure.  AgRP released from ARC NPY/AgRP 287 
neurons acts as a functional antagonist of α-MSH at melanocortin receptors [87, 90]. In healthy 288 
organisms, adipocyte stores are correlated with a rise in the levels of insulin and leptin.  Insulin and 289 
leptin, in turn, inhibit NPY/AgRP and stimulate POMC neurons, providing a feedback influence which 290 
acts to inhibit food intake [89]. However offspring of diabetic pregnant rats displayed increased 291 
hypothalamic insulin levels, and both at weaning [91] and as adults [82] had increased number of 292 
NPY-positive neurons in ARC. Thus changes in hypothalamic appetite regulatory peptides may 293 
contribute to the development of obesity and metabolic disturbances in the offspring of diabetic female 294 
rats [91] although experimental manipulations are needed in this model to convincingly demonstrate 295 
this role.  296 
 297 
In summary, current evidence suggests that insulin may play a role in the programming of both 298 
metabolism and reproductive systems during development, and these early alterations could lead to 299 
peripheral and central abnormalities in both systems during puberty and adulthood. A possible target 300 
for early insulin action is the hypothalamus, where information about metabolic status is conveyed to 301 
the reproductive functions. Thus, in case of prenatal programming by nutrients, where insulin 302 
functions are impaired, the disruptions of reproductive system are also observed. Importantly both 303 
under- and over-nutrition could lead to obesity and diabetes, diseases associated with insulin 304 
abnormalities, in which secondary abnormalities including disruptions of reproductive functions are 305 
present. Moreover, in support of long-term programming effects, studies have shown a perpetuation of 306 
type 2 diabetes into second-generation offspring in response to maternal under-nutrition [92-100]. 307 
 308 
4.  Insulin: reproductive effects at the level of the brain 309 
 310 
4.1 Is there local production of insulin in the CNS? Is there regulated transport across the blood-brain 311 
barrier? 312 
 313 
The first studies indicating a possible role of insulin within the CNS were performed in the 1960-70s 314 
[101, 102]. For example, Havrankova et al. [103] found that insulin is present in whole brain extracts 315 
of rats, and its concentration on average was 25 times higher than seen in plasma, with the 316 
hypothalamus being identified as the brain region with the highest insulin levels. This finding was 317 
consistent with previous data [104] showing that insulin receptors are widely distributed in the CNS of 318 
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rats. These observations raised the question of the source of insulin found in the brain. It was proposed 319 
that pancreatic insulin present in the plasma and cerebrospinal fluid was taken up and stored by cells 320 
in the brain [103]. However, the possibility of extrapancreatic insulin production in the brain was 321 
suggested by immunocytochemical studies revealing the presence in the brain of C-peptide 322 
(connecting peptide), a metabolic product of insulin biosynthesis. Insulin-like immunoreactivity was 323 
shown to be present in the brain of human, rats, mice, frogs and tortoise [105]. Additionally, post 324 
mortem studies on human brain revealed that concentration of insulin and C-peptide is much higher 325 
compared to its blood levels. Moreover, the highest concentration of insulin and C-peptide was found 326 
to be present in the hypothalamus [106, 107]. Importantly, it was also shown that metabolic status 327 
influenced the presence of C-peptide-like immunoreactivity in the brain. Rats fasted for 72 h showed a 328 
decrease in the hypothalamic C-peptide-like immunoreactivity, which was reversed by glucose 329 
administration.  In addition to the presence of C-peptide immunoreactivity, preproinsulin mRNA was 330 
also detected in the brain. Both in situ hybridization and immunocytochemisty showed the presence of 331 
preproinsulin mRNA and peptide in isolated enriched cultures of rabbit brain, restricted to neurons and 332 
absent in the glia [108]. Using in situ hybridization, the mRNA encoding preproinsulin was detected in 333 
the PVN but not in other regions of the rat brain [109]. However, these early findings have not been 334 
replicated, and whether local neuronal synthesis of insulin contributes to physiological actions of 335 
insulin remains to be demonstrated. 336 
 337 
Transport of peripheral insulin across the brain-blood barrier (BBB) may also be a factor in its action 338 
in the brain. In studies of intravenous infusions of insulin performed in dog, it was found that insulin 339 
levels also increased in the cerebrospinal fluid (CSF; [110]). Additionally, it was revealed that the 340 
increase in concentration of insulin in the CSF was not proportional to its increase in plasma, leading 341 
to the suggestion that insulin passes into the CSF by the way of saturable transport system [110-113]. 342 
Of relevance to the current review, it was noted that the BBB shows regional differences in insulin 343 
permeability, with the hypothalamus being one of the brain regions with the highest permeability, 344 
where insulin is transported over twice as fast as into the whole brain [114].  Insulin transport was also 345 
shown to be regulated by physiological state (e.g. fasting) and altered in genetically obese Zucker rats 346 
[92, 115], who also show lower levels of insulin in their brain compared to lean Zucker rats [116]. 347 
However, in contrast to Zucker rats, animals with diabetes induced by injections of alloxan or 348 
streptozotocin had an increased saturable transport of insulin across the BBB [117]. This discrepancy 349 
between these two models of diabetes can in part be explained by differences in the levels of insulin in 350 
the blood. Whereas the Zucker rats are insulin resistant and have elevated levels of insulin in serum, 351 
animals with diabetes induced with alloxan and streptozotocin are insulinopenic [112]. It was also 352 
proposed that one of the mechanism by which stress, manifested as increased glucocorticoid levels, 353 
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enhances appetite and increases body weight could be related to the inhibition of insulin transport into 354 
the brain [118]. 355 
 356 
4.2. Where does insulin act in the brain to regulate reproduction?  357 
 358 
Regardless of whether insulin is produced locally or not, there is strong evidence that many of 359 
insulin’s action on the brain’s reproductive system are mediated through direct actions on neuronal 360 
insulin receptors (IR). The most compelling evidence comes from the CNS-specific IR knockout 361 
mouse that exhibits hypogonadotropic hypogonadism [15]. Moreover, intracerebroventricular (i.c.v.) 362 
insulin administration has been shown to restore normal LH surges in STZ treated rats, despite the 363 
maintenance of peripheral diabetes-induced metabolic signals and metabolites (including 364 
hypoinsulinemia; [119]). IRs are widely distributed in the brain with highest concentrations in the 365 
olfactory bulb, hypothalamus, cerebral cortex, cerebellum and hippocampus [120]. Interestingly, an 366 
abundance of IRs are localized in areas that are well known to play a key role in reproduction such as 367 
the ARC, ventromedial hypothalamic nucleus (VMH), and preoptic area (POA; [15, 121-123]). These 368 
hypothalamic areas consist of potential sites for the action of insulin to control reproduction, and most 369 
recent attention has focused on specific identified subsets of neurons in these regions known to be 370 
involved in reproductive neuroendocrine control. 371 
 372 
4.3. GnRH neurons  373 
 374 
As the final common pathway in the control of mammalian reproductive neuroendocrine function, 375 
GnRH neurons were an obvious candidate as a target for insulin action. Based on cell line 376 
observations, insulin was originally thought to be acting directly on GnRH neurons via a functional IR 377 
[124, 125]. However,a recent study suggests otherwise. Deletion of IR from GnRH neurons had no 378 
effect on adult reproductive function in mice, as indicated by normal expression of estrous cyclicity 379 
[126]. Interestingly, in the sheep, even though there is an abundance of IRβ in the POA, GnRH 380 
neurons located there were devoid of immunoreactive IRβ [121].  These data taken together indicate 381 
that the influence of insulin on GnRH secretion is most likely not mediated directly, but instead via 382 
inputs other insulin-responsive neurons. One such afferent source that has been speculated to play this 383 
role is that of kisspeptin neurons of the POA and hypothalamus. 384 
 385 
4.4. Kisspeptin neurons 386 
 387 
The first known biological function of kisspeptin was in suppression of tumor metastasis, described in 388 
1996 by Lee et al.[127]. Later, in 2003, two independent groups of scientists, discover, that mutations 389 
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of the kisspeptin receptor KISS1R (GPR54), lead hypogonadotropic hypogonadism in humans, and a 390 
failure to enter puberty [128, 129]. These findings not only revolutionized the field of reproduction but 391 
also provided a missing link in understanding the neural regulation of the GnRH system. Fruitful 392 
studies of many researchers revealed a crucial role for kisspeptin in regulation of GnRH secretion 393 
[130], including the control of both GnRH pulses and the GnRH surge.  There are two major 394 
populations of kisspeptin neurons in the mammalian diencephalon: one located in the preoptic region 395 
and the other in the ARC.  The rostral population in rodents is located in the rostral periventricular 396 
region of the third ventricle (RP3V) and has been strongly implicated in the functional control of the 397 
GnRH and LH surge [131]. The caudal (ARC) population of kisspeptin cells express two other 398 
neuropeptides important for reproduction, neurokinin B (NKB) and dynorphin [132] Because of its co-399 
expression of the three distinct neuropeptides, these cells have been termed KNDy 400 
(Kisspeptin/NKB/Dynorphin) neurons [133], and they are thought to play a critical role in the 401 
generation of GnRH pulses [134, 135]. Because of their expression of nuclear steroid hormone 402 
receptors, both kisspeptin populations are believed to conveying the influence of gonadal steroids, 403 
such as estradiol and progesterone, onto GnRH neurons, and they are also believed to be important 404 
mediators for other types of signals that regulate GnRH neuronal activity.   In this regard, much 405 
attention has been focused upon their potential role in transmitting metabolic cues to GnRH neurons 406 
[1]. As puberty and reproduction are closely connected with metabolism, recent studies focused on 407 
role of Kisspeptin and its receptor, KISS1R, in metabolic control of both puberty and fertility.  408 
 409 
Sufficient body energy stores are indispensable for the reproductive axis to start functioning at 410 
puberty, and, not surprisingly, under-nutrition and the resulting state of negative energy balance is 411 
closely associated with a lack of or delay in puberty onset in animals [136, 137] and humans [138].  412 
Castellano et al., [139] using RT-PCR of whole hypothalamic fragments from prepubertal male and 413 
female rats collected after 72h of fasting found a decrease in hypothalamic Kiss1 mRNA levels and an 414 
increase in Kiss1R mRNA expression levels. Administration of kisspeptin i.c.v. to immature, 415 
undernourished female rats was sufficient to restore vaginal opening (a marker of puberty) in about 416 
60% of animals, and induce gonadotropin and estrogen secretion. Results of these studies suggest that 417 
negative energy balance caused by fasting induces a decrease in the kisspeptin expression, and that 418 
this decrease may in part be responsible for the pubertal deficit.  Similar studies conducted by Roa et 419 
al. [140] in adult rats also showed that intracerebral infusion of kisspeptin-10 in animals subjected to 420 
chronic undernutrition increased ovarian weights and circulating LH levels. After 7 days of kisspeptin 421 
infusion, no differences were found between vehicle-treated, and kisspeptin-treated animals subjected 422 
to continued under-nutrition. These data indicate that chronic undernutrition in adult female rats 423 
markedly altered the ability of the chronic kisspeptin infusion to restore normal reproductive functions 424 
(e.g. normal pattern of gonadotropin response to continuous infusion of kisspeptin-10). 425 
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Despite the evidence supporting a role for kisspeptin in linking metabolism and reproduction, there is 426 
controversy as to whether insulin is the mediating signal. For example, uncontrolled long term 427 
diabetes in female rats is characterized by lowered LH secretion and decreased hypothalamic kiss1 428 
mRNA[141]. Furthermore, the disturbance observed in the kisspeptin system appears to be causative 429 
to altered LH secretion as i.c.v kisspeptin administration reversed gonadotropin defects,  despite 430 
prevailing metabolic perturbations [141].  However, insulin does not appear to be the upstream 431 
mediator of decreased kisspeptin, as insulin infusion in male rats was not able to reverse the diabetes 432 
induced kiss1 mRNA and LH decrease [142]. Similarly, 50% caloric restriction or lactational negative 433 
energy balance decreased kiss1 mRNA in POA kisspeptin cells, and both kisspeptin and NKB mRNA 434 
in ARC KNDy cells of the rat, and this decrease was not reversed by sc insulin injections [35, 143]. In 435 
addition, in vitro studies showed that insulin failed to stimulate kisspeptin expression in hypothalamic 436 
cell line N6 [144]. By contrast, hyperinsulinemia produced by a bolus injection of insulin in the late 437 
follicular phase dramatically increased c-fos expression in ARC kisspeptin cells of sheep [145], 438 
although this effect could reflect either direct or indirect actions.  In addition, recent studies have 439 
shown a high percentage of IR colocalization in KNDy cells but not preoptic kisspeptin cells, nor in 440 
GnRH cells, in the sheep brain [121].  However, a recent study using transgenic techniques to 441 
specifically delete IR from kisspeptin cells produced mice that display a normal onset of puberty onset 442 
[146].  Thus, while studies to date suggest that kisspeptin and KNDy cells may be mediators of insulin 443 
action, they are by themselves likely not a critical component in insulin’s influence on reproduction, at 444 
least with respect to puberty. 445 
 446 
4.5. AgRP/POMC neurons 447 
 448 
In addition to KNDy cells, two additional populations of ARC neurons have been strongly implicated 449 
as mediators of insulin action: cells which express AgRP and NPY, and a separate population that 450 
expresses POMC and cocaine amphetamine related transcript (CART; [49]).  AgRP/NPY and 451 
POMC/CART neurons are well established as key regulators of glucose homeostasis, energy 452 
metabolism and body weight [147], and may also act as a link between metabolism and reproduction 453 
[148]. First, these cells contain IR in sheep [149] and rodents [150].  While deletion of IR alone in 454 
AgRP or POMC neurons is reported to produce no gross reproductive abnormalities [151], deletion of 455 
both IR and leptin receptors in POMC neurons produced mice with ovarian abnormalities and elevated 456 
serum testosterone levels that resemble the symptoms of PCOS [152]. Second, insulin directly 457 
regulates the electrophysiological properties of these neurons; POMC neurons are activated [153] and 458 
NPY/AgRP inhibited by insulin [154]. Third, recent evidence suggests that NPY/AgRP and POMC 459 
derived peptides such as alpha-melanocyte-stimulating hormone (ɑ-MSH), are able to directly 460 
influence GnRH neuron excitability [155]. Fourth, there is anatomical evidence that projections from 461 
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NPY/AgRP and POMC/CART neurons directly contact GnRH cells in a number of species [156, 157]. 462 
Finally, there is preliminary evidence of local connections from AgRP and POMC neurons onto 463 
kisspeptin (KNDy) neurons in the ARC [158]. Thus, both AgRP/NPY and POMC/CART neurons 464 
appear to be well positioned to influence GnRH secretion directly as well as by indirect routes. The 465 
manner in which each of these ARC populations, together with KNDy/kisspeptin neurons and perhaps 466 
other neuronal populations, contribute to insulin’s effects on GnRH neuroendocrine function will need 467 
to be fully elucidated by future work.  468 
 469 
 470 
5. Clinical relevance  471 
 472 
Diabetes is usually lifelong (chronic) disease with two major types. Type 1 diabetes mellitus may 473 
result primarily from the pancreas’ failure to produce enough insulin, while type 2 diabetes mellitus 474 
result from a condition of insulin resistance. Both conditions are of great concern, but 90% of all 475 
diabetes cases are type 2 diabetes mellitus, which affects more than 285 million people worldwide. 476 
Thus, understanding the role of insulin both acting peripherally as well as within the CNS and its 477 
dysfunction in conditions such as diabetes could lead to development of better clinical treatments and 478 
improvement of heath of millions of people worldwide.   479 
 480 
In addition to primary metabolic deficits, diabetic patients show disruptions of reproductive function 481 
manifested as hypogonadism or infertility [159-161].  Most drugs available to treat diabetes mellitus 482 
act either in the pancreas by increasing insulin secretion, or in tissues such as the liver or muscle by 483 
improving insulin sensitivity. However, in view of recent studies discussed above suggesting that the 484 
brain also plays a critical role in the regulation of glucose homeostasis, this organ has also received 485 
attention as a promising new target of drugs aiming to treat both diabetes mellitus type 1 and type 2 486 
[5]. However, although the clinical association between insulin deficiency/resistance and reproductive 487 
defects is well established, whether the underlying mechanisms include actions of insulin or insulin 488 
resistance at a neural level remains to be determined. 489 
 490 
There is substantial evidence that hyperinsulinemia and insulin resistance when associated with 491 
obesity has a negative impact on human female fertility.  For example, weight reduction in obese, 492 
infertile women is associated with an increase in the frequency of ovulation and the likelihood of 493 
pregnancy. Even among ovulatory women, increasing body mass index (BMI) is associated with 494 
decreasing spontaneous pregnancy rates, with the mechanism thought to be related to adverse effects 495 
of elevated insulin levels on ovarian function [162, 163]. In addition, there is a causal association 496 
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between maternal obesity and pregnancy complications, with the risk of pregnancy complications 497 
increasing with obesity.  498 
 499 
Obesity has also a negative influence on the outcome of treatments for infertility (e.g. insufficient 500 
follicular development, lower oocyte counts, poorer outcomes from in vitro fertilization) [166-168]. 501 
Weight loss in obese subfertile women leads to favorable hormonal changes and an improvement in 502 
fertility. Metformin treatment of obese patients with infertility due to PCOS facilitates ovulation, 503 
supporting the idea that insulin resistance impairs normal oocyte development [169].  In this view, 504 
hyperinsulinemia stimulates ovarian androgen secretion directly and indirectly (by stimulating LH 505 
release or increasing ovarian LH receptors) [170, 171].  Extreme hyperinsulinemia (in hereditary cases 506 
caused by insulin receptor mutations or lipodystrophy) excessively stimulates the IGF-1 signal 507 
transduction pathway in ovarian theca cells, and results in increased androgen production by blocking 508 
the normal cellular down-regulation of response to LH [172, 173]. In general, all treatments that lower 509 
insulin levels, including weight loss or treatment with insulin sensitizers, improve female reproductive 510 
function and clinical pregnancy but there is still no evidence that metformin improves live birth rates. 511 
Therefore, the role of metformin in improving reproductive outcomes in women with PCOS appears to 512 
be limited [174, 175]. While there is clear evidence that ovary is a major target of insulin action in 513 
these interventions, the possibility also exists that some of the clinical improvements seen in these 514 
patients are due to normalizing insulin actions in the CNS [53, 59, 176]. 515 
 516 
There is much less evidence concerning impact that hyperinsulinemia has on male fertility, 517 
particularly at a CNS level.  It is known that insulin acts at very early stages of testicular development 518 
as modulator of specific genes, e.g. Sry and Sox9, which are essential for male sex determination 519 
[177].   In addition to its early actions, insulin also plays a role in the postnatal testes, regulating germ 520 
cell production before and after puberty, affecting testes size and FSH production [178]. Interestingly, 521 
the testes is an extra-pancreatic source of insulin [179], and STZ-induced diabetes has been shown to 522 
diminish testicular insulin expression in the rat [180].   To investigate the role of the testicular insulin, 523 
a diabetic model of Akita mouse was created with nonfunctional insulin gene (ins2) in both testes and 524 
pancreas.  Homozygous mice showed onset of diabetes prior to puberty and thereafter were infertile 525 
with small sized testes and arrested spermatogenesis. Exogenous insulin treatment improved testicular 526 
size and function, but because of the blood-testis barrier it was presumed that insulin in this study was 527 
exerting its effects indirectly. The authors suggested one possible site of action responsible for the 528 
restoration of testicular function was the hypothalamus; however, other sites of action were also 529 
possible [179]. 530 
While reports of genetic syndromes of severe insulin resistance have included prominent descriptions 531 
of ovarian dysfunction [181], changes in male reproductive function have rarely been reported. On the 532 
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other hand, obese men with insulin resistance frequently exhibit reduced levels of gonadotropins and 533 
testosterone, impaired semen parameters, altered androgen-to-estrogen ratios, and erectile problems 534 
[182].   However, again, whether any of these changes are due to the primary effects of changes in 535 
insulin signaling at a neural level are not known. 536 
6. Conclusions 537 
While there is ample evidence to support insulin as a key regulator of reproductive function, current 538 
knowledge of its neural actions with respect to reproduction is in many instances incomplete and 539 
rudimentary.  Insulin is clearly an important regulator of pulsatile and surge GnRH/LH secretion, but 540 
whether these effects of due to insulin, per se, or whether changes in accompanying peripheral signals 541 
and metabolites may be involved, remains to be determined.  Insulin appears to play a primarily 542 
permissive role in the control of pulsatile GnRH secretion, and those effects are due to different 543 
aspects (amplitude vs. timing) of the generation of the GnRH/LH surge responsible for ovulation.   544 
There is much epidemiological and experimental evidence to suggest a role for insulin in fetal 545 
programming of the metabolic and reproductive axes, but it is not known whether these long-term 546 
effects are due to primary actions on the developing brain.   Recent preliminary evidence in the sheep 547 
suggests that there may be a convergence of insulin and gonadal hormones early in development 548 
responsible for programming of reproductive neuroendocrine circuitry.  Specifically, co-treatment of 549 
insulin sensitizer blocked the effect of prenatal testosterone on arcuate AgRP cell number in female 550 
sheep hypothalamus suggesting that a common mediator involving both insulin and androgen 551 
signaling is responsible for the prenatal programming of this hypothalamic circuitry.  However, again, 552 
whether these effects are due to primary actions of insulin on the developing brain, or due to effects on 553 
maternal or placental function, remains to be explored. 554 
At a neural level, the specific brain targets of insulin have been examined which may be involved in 555 
relaying its influence in reproduction: these include GnRH neurons, the final common pathway 556 
mediating control of the hypothalamic-pituitary gonadal axis, as well as upstream neurons, such as 557 
those containing the neuropeptides, kisspeptin, AgRP, and POMC.  While data is mixed as to whether 558 
insulin receptors are present in GnRH neurons, there is clear evidence of their presence in the other 559 
cell types.  While kisspeptin neurons may not by themselves be critical components in insulin’s effects 560 
on reproduction [146], insulin receptors in POMC neurons may be more important since deletion of IR 561 
leads to adult female reproductive deficits [152], and the contribution of AgRP neurons to this 562 
influence have yet to be specifically investigated. Multiple anatomical interconnections among these 563 
neuronal subpopulations, however, suggest that they may comprise a redundant network that mediates 564 
insulin’s reproductive actions upon GnRH neuronal activity and neuroendocrine output. 565 
17 
 
Finally, clinical evidence clearly implicates insulin deficiency/resistance in adult human female 566 
fertility, but whether these effects are due to primary actions upon reproductive neuroendocrine 567 
circuitry, or are exerted at the level of the pituitary or gonads, is not known.  Further, while there is 568 
growing consensus of the importance of insulin signaling in the central control of reproduction, well-569 
defined experimental models are needed both in the adult and development nervous system to 570 
determine insulin’s mechanisms of action independent of associated changes in metabolic signals.  571 
The ability to selectively manipulate components of insulin signaling in a cell-specific manner within 572 
defined neuronal subpopulations by transgenic approaches [138] presents such an opportunity, but will 573 
also need to coupled with careful and detailed physiological models of adult reproductive function in 574 
order to ensure the effective clinical translation of this knowledge in the future. 575 
576 
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